Regarding "Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma".
作者信息
Walker David A, Azizi Amedeo A, Liu Jo-Fen, Sehested Astrid, Jaspan Timothy, Pemp Berthold, Simmons Ian, Ferner Rosalie, Grill Jacques, Hargrave Darren, Driever Pablo Hernáiz, Evans D Gareth, Opocher Enrico
机构信息
Children's Brain Tumour Research Centre, University of Nottingham, UK.
Department of Pediatrics and Adolescent Medicine, Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Medical University of Vienna, Austria.
出版信息
Neurooncol Pract. 2020 Aug 17;7(5):572-573. doi: 10.1093/nop/npaa031. eCollection 2020 Oct.
Abstract
摘要
相似文献
1
Regarding "Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma".关于“神经肿瘤学实践临床辩论：小儿低级别胶质瘤的靶向治疗与传统化疗”。
Neurooncol Pract. 2020 Aug 17;7(5):572-573. doi: 10.1093/nop/npaa031. eCollection 2020 Oct.
2
Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.神经肿瘤学实践临床辩论：小儿低级别胶质瘤的靶向治疗与传统化疗
Neurooncol Pract. 2020 Jan;7(1):4-10. doi: 10.1093/nop/npz033. Epub 2019 Aug 13.
3
Pediatric low-grade glioma in the era of molecular diagnostics.儿童低级别胶质瘤的分子诊断时代。
Acta Neuropathol Commun. 2020 Mar 12;8(1):30. doi: 10.1186/s40478-020-00902-z.
4
A comprehensive approach in high-grade glioma management: position statement from the Neuro-Oncology Scientific Club (NOSC), Shiraz, Iran.高级别胶质瘤管理的综合方法：伊朗设拉子神经肿瘤科学俱乐部（NOSC）的立场声明
Ger Med Sci. 2017 Feb 28;15:Doc05. doi: 10.3205/000246. eCollection 2017.
5
Response Assessment in Pediatric Neuro-Oncology: Implementation and Expansion of the RANO Criteria in a Randomized Phase II Trial of Pediatric Patients with Newly Diagnosed High-Grade Gliomas.儿童神经肿瘤学中的疗效评估：在新诊断的高级别胶质瘤儿科患者的随机II期试验中实施和扩展RANO标准
AJNR Am J Neuroradiol. 2016 Sep;37(9):1581-7. doi: 10.3174/ajnr.A4782. Epub 2016 Apr 28.
6
Contemporary management of low--grade glioma: a paradigm shift in neuro-oncology.低级别胶质瘤的当代管理：神经肿瘤学中的范式转变。
Pract Neurol. 2017 Jun;17(3):183-190. doi: 10.1136/practneurol-2017-001604. Epub 2017 Mar 18.
7
Procarbazine, lomustine and vincristine for recurrent high-grade glioma.丙卡巴肼、洛莫司汀和长春新碱用于复发性高级别胶质瘤。
Cochrane Database Syst Rev. 2017 Jul 26;7(7):CD011773. doi: 10.1002/14651858.CD011773.pub2.
8
Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy.对儿科神经肿瘤患者进行靶向二代测序可改善诊断、识别致病性种系突变并指导靶向治疗。
Neuro Oncol. 2017 May 1;19(5):699-709. doi: 10.1093/neuonc/now254.
9
One year of procarbazine lomustine and vincristine is poorly tolerated in low grade glioma: a real world experience in a national neuro-oncology centre.替莫唑胺治疗脑胶质瘤 1 年耐受性差：国家神经肿瘤中心的真实世界经验。
BMC Cancer. 2021 Feb 8;21(1):140. doi: 10.1186/s12885-021-07809-5.
10
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.儿童低级别胶质瘤的反应评估：来自儿童神经肿瘤学反应评估（RAPNO）工作组的建议。
Lancet Oncol. 2020 Jun;21(6):e305-e316. doi: 10.1016/S1470-2045(20)30064-4.
引用本文的文献
1
Optic Pathway Gliomas in Pediatric Population-Current Approach in Diagnosis and Management: Literature Review.儿童视神经通路胶质瘤——诊断与管理的当前方法：文献综述
J Clin Med. 2023 Oct 24;12(21):6709. doi: 10.3390/jcm12216709.
2
A new era for optic pathway glioma: A developmental brain tumor with life-long health consequences.视神经通路胶质瘤的新时代：一种对终生健康有影响的发育性脑肿瘤。
Front Pediatr. 2023 Mar 24;11:1038937. doi: 10.3389/fped.2023.1038937. eCollection 2023.
本文引用的文献
1
NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat.NF1 视神经通路胶质瘤：分析视觉预后的风险因素和治疗指征。
Neuro Oncol. 2021 Jan 30;23(1):100-111. doi: 10.1093/neuonc/noaa153.
2
Neuro-Oncology Practice Clinical Debate: targeted therapy vs conventional chemotherapy in pediatric low-grade glioma.神经肿瘤学实践临床辩论：小儿低级别胶质瘤的靶向治疗与传统化疗
Neurooncol Pract. 2020 Jan;7(1):4-10. doi: 10.1093/nop/npz033. Epub 2019 Aug 13.
3
Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma.重新审视放射治疗在儿童低级别胶质瘤中的作用
J Clin Oncol. 2019 Dec 10;37(35):3335-3339. doi: 10.1200/JCO.19.01270. Epub 2019 Sep 9.
4
A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma - A final report.一项欧洲随机对照试验，在针对儿童（≤16岁）低级别胶质瘤的18个月治疗方案中，在标准长春新碱和卡铂诱导治疗基础上加用依托泊苷——最终报告。
Eur J Cancer. 2017 Aug;81:206-225. doi: 10.1016/j.ejca.2017.04.019. Epub 2017 Jun 22.
5
Normative visual acuity in infants and preschool-aged children in Sydney.悉尼婴幼儿及学龄前儿童的正常视力
Acta Ophthalmol. 2014 Nov;92(7):e521-9. doi: 10.1111/aos.12366. Epub 2014 Mar 9.
6
Long-term follow-up of the multicenter, multidisciplinary treatment study HIT-LGG-1996 for low-grade glioma in children and adolescents of the German Speaking Society of Pediatric Oncology and Hematology.多中心、多学科治疗研究 HIT-LGG-1996 对德语区儿科肿瘤学和血液学学会儿童和青少年低级别胶质瘤的长期随访。
Neuro Oncol. 2012 Oct;14(10):1265-84. doi: 10.1093/neuonc/nos202. Epub 2012 Aug 31.
7
A multivariate analysis of factors determining tumor progression in childhood low-grade glioma: a population-based cohort study (CCLG CNS9702).多因素分析确定儿童低级别胶质瘤肿瘤进展的因素：基于人群的队列研究（CCLG CNS9702）。
Neuro Oncol. 2010 Dec;12(12):1257-68. doi: 10.1093/neuonc/noq092. Epub 2010 Sep 22.
8
Are norms based on the original Teller Acuity Cards appropriate for use with the new Teller Acuity Cards II?基于原始泰勒视力卡的标准适用于新的泰勒视力卡II吗？
J AAPOS. 2005 Oct;9(5):475-9. doi: 10.1016/j.jaapos.2005.04.011.
9
Monocular acuity norms for the Teller Acuity Cards between ages one month and four years.1个月至4岁儿童使用Teller视力卡的单眼视力标准。
Invest Ophthalmol Vis Sci. 1995 Mar;36(3):671-85.
Zotero 插件